NextCell Pharma Feed

2025-09-18 12:33:09 NextCell Pharma AB meddelar CFO-förändring

2025-09-18 12:33:09 NextCell Pharma AB announces CFO transition

2025-08-21 16:00:00 Kommuniké från extra bolagsstämma i NextCell Pharma AB (publ) 1,15 SEK | -2,38% | 0,34 MSEK

2025-07-24 07:00:00 NextCell Pharma AB: NextCell Pharma offentliggör Delårsrapport 3 för 2024/2025 1,30 SEK | +13,24% | 0,72 MSEK

2025-07-24 07:00:00 NextCell Pharma AB: NextCell Pharma publishes its Interim Report 3 2024/2025 1,30 SEK | +13,24% | 0,72 MSEK

2025-07-14 08:50:00 NextCell Pharma AB: NextCell lyfts fram i FUJIFILMs strategiska vision enligt GEN 1,02 SEK | +0,59% | 1,11 MSEK

2025-07-14 08:50:00 NextCell Pharma AB: NextCell Highlighted in FUJIFILM's Strategic Vision, According to GEN 1,02 SEK | +0,59% | 1,11 MSEK

2025-07-10 12:03:18 Kallelse till extra bolagsstämma i NextCell Pharma AB (publ) 1,04 SEK | -1,89% | 0,23 MSEK

2025-07-03 08:45:00 NextCell Pharma AB: Republishing of: NextCell announces strategic collaboration with FUJIFILM Biosciences 1,05 SEK | +0,38% | 0,44 MSEK

2025-07-03 08:45:00 NextCell Pharma AB: Återpublicering av: NextCell tillkännager strategiskt samarbete med FUJIFILM Biosciences 1,05 SEK | +0,38% | 0,44 MSEK

2025-06-13 13:00:00 NextCell Pharma AB: Alla patienter har behandlats i ProTrans-Young-studien 1,03 SEK | -3,02% | 1,26 MSEK

2025-06-13 13:00:00 NextCell Pharma AB: All Patients Successfully Treated in ProTrans-Young Study 1,03 SEK | -3,02% | 1,26 MSEK

2025-06-02 13:15:00 NextCell Pharma AB: NextCell Pharma announces outcome of exercise of TO2 and resolves on directed share issues to guarantors 1,09 SEK | +0,93% | 0,33 MSEK

2025-06-02 13:15:00 NextCell Pharma AB: NextCell Pharma offentliggör utfall av nyttjande av TO2 och beslutar om riktade nyemissioner till garanter 1,09 SEK | +0,93% | 0,33 MSEK

2025-05-28 13:03:25 NextCell Pharma AB: NextCell Pharma receives additional declarations of intent regarding exercise of TO2 1,00 SEK | -1,77% | 0,48 MSEK

2025-05-28 13:03:25 NextCell Pharma AB: NextCell Pharma erhåller ytterligare avsiktsförklaringar avseende nyttjande av TO2 1,00 SEK | -1,77% | 0,48 MSEK

2025-05-28 09:50:36 NextCell Pharma AB: Angela Vollstedt joins NextCell Pharma's Board of Advisors to Strengthen Scientific and Manufacturing Strategy Ahead of Licensing Discussions 1,00 SEK | -1,77% | 0,48 MSEK

2025-05-28 09:50:36 NextCell Pharma AB: Angela Vollstedt ansluter till NextCells Board of Advisors - stärker strategi för tillverkning och licensiering 1,00 SEK | -1,77% | 0,48 MSEK

2025-05-26 13:00:00 NextCell Pharma AB: NextCell Receives US Patent for MSC Prediction Algorithm 1,03 SEK | -0,39% | 0,60 MSEK

2025-05-26 13:00:00 NextCell Pharma AB: NextCell beviljas amerikanskt patent för MSC-prediktionsalgoritm 1,03 SEK | -0,39% | 0,60 MSEK

2025-05-23 12:30:00 NextCell Pharma AB: NextCell Pharma erhåller avsiktsförklaringar, teckningsförbindelser och toppgarantier avseende nyttjande av TO2 1,03 SEK | -0,96% | 0,15 MSEK

2025-05-23 12:30:00 NextCell Pharma AB: NextCell Pharma receives declarations of intent, subscription undertakings and top guarantees regarding exercise of TO2 1,03 SEK | -0,96% | 0,15 MSEK

2025-05-20 09:40:00 NextCell Pharma AB: NextCell meddelar strategiskt samarbete med Fujifilm Irvine Scientific 1,04 SEK | -1,89% | 0,47 MSEK

2025-05-20 09:40:00 NextCell Pharma AB: NextCell announces strategic collaboration with Fujifilm Irvine Scientific 1,04 SEK | -1,89% | 0,47 MSEK

2025-05-19 13:00:00 NextCell Pharma AB: Eric Strati ansluter till NextCells Board of Advisors för att stödja den kommersiella strategin för ProTrans 1,06 SEK | +2,51% | 0,43 MSEK

2025-05-19 13:00:00 NextCell Pharma AB: Eric Strati Joins NextCell Pharma's Board of Advisors to Support Commercial Strategy for ProTrans 1,06 SEK | +2,51% | 0,43 MSEK

2025-05-16 08:00:00 NextCell Pharma AB: The exercise period for NextCell Pharma's warrants of series TO2 begins today 1,03 SEK | -1,52% | 0,31 MSEK

2025-05-16 08:00:00 NextCell Pharma AB: Nyttjandeperioden för NextCell Pharmas teckningsoptioner av serie TO2 inleds idag 1,03 SEK | -1,52% | 0,31 MSEK

2025-05-15 13:25:00 NextCell Pharma AB: Åttaårige Hugo - en vardag med typ 1-diabetes och deltagande i ProTrans-studien 1,05 SEK | +0,38% | 0,47 MSEK

2025-05-15 13:25:00 NextCell Pharma AB: Eight-Year-Old Hugo - Living with Type 1 Diabetes and Participating in the ProTrans Study 1,05 SEK | +0,38% | 0,47 MSEK

2025-05-07 14:20:00 NextCell Pharma AB: Study published in Nature Medicine shows promising results in Alzheimer's disease - supports the development of ProTrans at NextCell 1,12 SEK | -7,89% | 1,67 MSEK

2025-05-07 14:20:00 NextCell Pharma AB: Studie publicerad i Nature Medicine visar lovande resultat vid Alzheimers sjukdom - stärker utvecklingen av ProTrans hos NextCell 1,12 SEK | -7,89% | 1,67 MSEK

2025-04-25 07:30:00 NextCell Pharma AB: NextCell Pharma publishes its Interim Report 2 2024/2025 1,12 SEK | -2,27% | 0,50 MSEK

2025-04-25 07:30:00 NextCell Pharma AB: NextCell Pharma offentliggör Delårsrapport 2 för 2024/2025 1,12 SEK | -2,27% | 0,50 MSEK

2025-04-24 14:10:00 NextCell Pharma AB: NextCell presenterar detaljer från den administrativa delgruppsanalysen av ProTrans-Young 1,15 SEK | +14,71% | 0,92 MSEK

2025-04-24 14:10:00 NextCell Pharma AB: NextCell presents detailed analysis of the administrative report from ProTrans-Young 1,15 SEK | +14,71% | 0,92 MSEK

2025-04-23 14:15:00 NextCell Pharma AB: NextCell presenterar kvartalsrapport 1,00 SEK | +6,28% | 0,42 MSEK

2025-04-23 14:15:00 NextCell Pharma AB: NextCell Presents Quarterly Report 1,00 SEK | +6,28% | 0,42 MSEK

2025-04-15 13:00:00 NextCell Pharma AB: NextCells vd Mathias Svahn förklarar de senaste resultaten från ProTrans-Young studien och ger sin syn på framtiden 0,81 SEK | -13,84% | 2,27 MSEK

2025-04-15 13:00:00 NextCell Pharma AB: NextCell CEO Mathias Svahn explains the latest results from ProTrans-YOUNG and his vision for the way forward 0,81 SEK | -13,84% | 2,27 MSEK

2025-04-09 08:50:00 NextCell Pharma AB: NextCells CSO får förtroendeuppdrag inom global branschorganisation 1,23 SEK | -4,96% | 1,09 MSEK

2025-04-09 08:50:00 NextCell Pharma AB: NextCell's CSO elected Vice President Elect for ISCT Europe 1,23 SEK | -4,96% | 1,09 MSEK

2025-04-07 18:05:00 NextCell Pharma AB: Subgroup Analysis: NextCell Presents Preliminary One-Year Results from the Older Age Group in ProTrans-Young 1,29 SEK | -59,11% | 9,93 MSEK

2025-04-07 18:05:00 NextCell Pharma AB: Delgruppsanalys: NextCell presenterar preliminära 1-årsresultat från den äldre åldersgruppen i ProTrans-Young 1,29 SEK | -59,11% | 9,93 MSEK

2025-03-28 10:00:57 NextCell Pharma AB: NextCells CSO invald i styrelsen för ATMP Sweden 2,88 SEK | -4,00% | 0,39 MSEK

2025-03-28 10:00:57 NextCell Pharma AB: NextCell's CSO Appointed to the Board of ATMP Sweden 2,88 SEK | -4,00% | 0,39 MSEK

2025-03-19 08:45:00 NextCell Pharma AB: Recognition for NextCell's CSO from the International Society of Cell and Gene Therapy 3,02 SEK | -4,43% | 0,85 MSEK

2025-03-19 08:45:00 NextCell Pharma AB: NextCells CSO nominerad till vice president för International Society of Cell and Gene Therapy 3,02 SEK | -4,43% | 0,85 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

NextCell Pharma

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden